Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The artificial intelligence and machine learning in lung cancer immunotherapy
Qing Gao, Luyu Yang, Mingjun Lu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review
Diny Dixon, Hina Sattar, Natalia Moros, et al.
Cureus (2024)
Open Access | Times Cited: 40
Unraveling the role of low‐density lipoprotein‐related genes in lung adenocarcinoma: Insights into tumor microenvironment and clinical prognosis
Pengpeng Zhang, Xinyi Wu, Dingli Wang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4479-4495
Closed Access | Times Cited: 19
Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes
Zainab Gandhi, Priyatham Gurram, Birendra Amgai, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5236-5236
Open Access | Times Cited: 40
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12
A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma
Jie Peng, Dan Zou, Xudong Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
A Holistic Approach to Implementing Artificial Intelligence in Lung Cancer
Seyed Masoud HaghighiKian, Ahmad Shirinzadeh-Dastgiri, Mohammad Vakili-Ojarood, et al.
Indian Journal of Surgical Oncology (2024) Vol. 16, Iss. 1, pp. 257-278
Closed Access | Times Cited: 7
Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review
Tanya Sinha, Aiman Khan, Manahil Awan, et al.
Cureus (2024)
Open Access | Times Cited: 6
Enhancing lung cancer diagnosis with data fusion and mobile edge computing using DenseNet and CNN
Chengping Zhang, Muhammad Aamir, Yurong Guan, et al.
Journal of Cloud Computing Advances Systems and Applications (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
From darkness to light: Targeting CAFs as a new potential strategy for cancer treatment
Dong Hua, Weijing Wang, Shuai Liang, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113482-113482
Closed Access | Times Cited: 4
Integrating AI into Cancer Immunotherapy—A Narrative Review of Current Applications and Future Directions
David B. Olawade, Aanuoluwapo Clement David-Olawade, Temitope Adereni, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 24-24
Open Access
Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologist
Paul Hofman, Iordanis Ourailidis, Eva Romanovsky, et al.
Lung Cancer (2025) Vol. 200, pp. 108110-108110
Closed Access
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer
Serafeim‐Chrysovalantis Kotoulas, Dionysios Spyratos, Κonstantinos Porpodis, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 882-882
Open Access
The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC Cancer
Fausto Omero, Desirèe Speranza, Giuseppe Murdaca, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 491-491
Open Access
Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions
Ellen N. Huhulea, Lillian Huang, Shirley Eng, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 951-951
Open Access
Artificial Intelligence in Thoracic Surgery: A Review Bridging Innovation and Clinical Practice for the Next Generation of Surgical Care
Vasileios Leivaditis, Andreas Maniatopoulos, Henning Lausberg, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2729-2729
Open Access
LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin
Hao Feng, Dengfei Xu, Chenyang Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Microbiota-induced inflammatory responses in bladder tumors promote epithelial-mesenchymal transition and enhanced immune infiltration
Qiang Li, Yichao Sun, Kun Zhai, et al.
Physiological Genomics (2024) Vol. 56, Iss. 8, pp. 544-554
Closed Access | Times Cited: 3
A narrative review on perioperative systemic therapy in non-small cell lung cancer
Robert Hsu, Zhaohui Arter, Darin Poei, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 4, pp. 931-954
Open Access | Times Cited: 3
Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
Ran Qin, Tianqiang Jin, Feng Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Explainable lung cancer classification with ensemble transfer learning of VGG16, Resnet50 and InceptionV3 using grad-cam
Yogesh Kumaran S, J. Jospin Jeya, T R Mahesh, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma
Damayanti Das Ghosh, Hannah G. McDonald, Rajeswari Dutta, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1785-1785
Open Access | Times Cited: 2
Just how transformative will AI/ML be for immuno-oncology?
Daniel Bottomly, Shannon K. McWeeney
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e007841-e007841
Open Access | Times Cited: 2
Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma
Yong Li, Yunxiang Cai, Longfei Ji, et al.
PeerJ (2024) Vol. 12, pp. e17746-e17746
Open Access | Times Cited: 2
Current diagnosis and treatment of salivary gland-type tumors of the lung
Yoshitsugu Horio, Hiroaki Kuroda, Katsuhiro Masago, et al.
Japanese Journal of Clinical Oncology (2023) Vol. 54, Iss. 3, pp. 229-247
Closed Access | Times Cited: 5
CASCADE: Context-Aware Data-Driven AI for Streamlined Multidisciplinary Tumor Board Recommendations in Oncology
Dania Daye, Regina Parker, Satvik Tripathi, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1975-1975
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top